noladin ether

Noladin ether is a lipid of Glycerolipids (GL) class. The involved functions are known as 5-(carboxyamino)imidazole ribonucleotide mutase activity and Competitive inhibition. Noladin ether often locates in Synaptosomes and Tissue membrane. The associated genes with Noladin Ether are IMPACT gene. The related lipids are noladin ether and Fatty Alcohols.

Cross Reference

Introduction

To understand associated biological information of noladin ether, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with noladin ether?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with noladin ether

PubChem Associated disorders and diseases

What pathways are associated with noladin ether

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with noladin ether?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with noladin ether?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with noladin ether?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with noladin ether?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with noladin ether?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with noladin ether

Download all related citations
Per page 10 20 50 | Total 39
Authors Title Published Journal PubMed Link
pmid:
Hanus L et al. 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11259648
Laine K et al. Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid. 2002 Invest. Ophthalmol. Vis. Sci. pmid:12356827
Milton NG Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide. 2002 Neurosci. Lett. pmid:12384227
Fezza F et al. Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues. 2002 FEBS Lett. pmid:11904167
van der Stelt M et al. Acute neuronal injury, excitotoxicity, and the endocannabinoid system. 2002 Oct-Dec Mol. Neurobiol. pmid:12428763
Oka S et al. Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species. 2003 J. Neurochem. pmid:12787057
Appendino G et al. Homologues and isomers of noladin ether, a putative novel endocannabinoid: interaction with rat cannabinoid CB(1) receptors. 2003 Bioorg. Med. Chem. Lett. pmid:12467613
Juntunen J et al. Synthesis, in vitro evaluation, and intraocular pressure effects of water-soluble prodrugs of endocannabinoid noladin ether. 2003 J. Med. Chem. pmid:14584958
Guo J and Ikeda SR Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. 2004 Mol. Pharmacol. pmid:14978245
Duncan M et al. Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptor. 2004 Br. J. Pharmacol. pmid:15148262
Hayase T et al. Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands. 2005 Behav Pharmacol pmid:16148444
Venderova K et al. Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus. 2005 Exp. Neurol. pmid:15899265
Sancho R et al. Mechanisms of HIV-1 inhibition by the lipid mediator N-arachidonoyldopamine. 2005 J. Immunol. pmid:16148147
Straiker A and Mackie K Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. 2005 J. Physiol. (Lond.) pmid:16179366
Shoemaker JL et al. Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors. 2005 J. Pharmacol. Exp. Ther. pmid:16081674
Shoemaker JL et al. The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors. 2005 J. Pharmacol. Exp. Ther. pmid:15901805
Avraham Y et al. Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice. 2005 Brain Res. Bull. pmid:15763177
Unzicker C et al. Hippocampal cannabinoid-1 receptor upregulation upon endothelin-B receptor deficiency: a neuroprotective substitution effect? 2005 Neurochem. Res. pmid:16341592
Njie YF et al. Noladin ether acts on trabecular meshwork cannabinoid (CB1) receptors to enhance aqueous humor outflow facility. 2006 Invest. Ophthalmol. Vis. Sci. pmid:16639008